Rhode Island man becomes first patient to receive infusion of controversial new Alzheimer s drug dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.
Eli Lilly drug shows significant results in slowing Alzheimerâs
The experimental drug, donanemab, was studied at two R.I. hospitals
By Alexa Gagosz Globe Staff,Updated March 15, 2021, 2:32 p.m.
Email to a Friend
Dr. Stephen Salloway is the director of the Memory and Aging Program at Butler Hospital, where he led the TRAILBLAZER study. He is also a professor of psychiatry and human behavior and of neurology at Brown Universityâs Warren Alpert Medical School.Nick Dentamaro/Brown University
PROVIDENCE â Rhode Island is once again playing a critical role in the development of promising potential treatments for Alzheimerâs disease.